UTHR financials
United Therapeutics (UTHR) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
UTHR income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $3.18B | $2.80B | $1.52B | $1.33B | 27.86 |
| 2024 | $2.88B | $2.57B | $1.38B | $1.20B | 24.64 |
| 2023 | $2.33B | $2.07B | $1.18B | $984.80M | 19.81 |
| 2022 | $1.94B | $1.79B | $979.70M | $727.30M | 15.00 |
| 2021 | $1.69B | $1.56B | $555.90M | $475.80M | 10.06 |
| 2020 | $1.48B | $1.38B | $593.60M | $514.80M | 11.54 |
- UTHR revenue was $3.18B in fiscal 2025, net income $1.33B.
Updated 2026-11-03 02:02 UTC